BridgeMD
Compares treatment options for Thoracic
Official title Rhomboid Intercostal Sub Serratus Plane Block Versus Serratus Anterior Plane Block in Thoractomy
ClinicalTrials.gov ID: NCT06856538
What this study is testing
What is Bupivacain?
Bupivacain is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for thoracic.
Also referred to as Marcaine 0.25%.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The objective of the current study is to compare the efficacy of the analgesic effect of ultrasound-guided unilateral Rhomboid intercostal and sub serratus plane block (RISS) versus Serratus anterior plane block (SAPB) in Thoracotomy incision.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged 18-70 years.
- Patients scheduled for unilateral Thoracotomy.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Patients who are candidates for general anesthesia.
- No history of severe allergies to local anesthetics or other medications used during the procedure.
You likely can't join if
- ASA PS class ≥ IV patients.
- obese (BMI ≥ 35) patients.
- Patients with uncontrolled cardiovascular.
- patients with neurological deficits, cardiopulmonary, hepatorenal , or metabolic diseases; anticoagulants; any drug allergies.
- Patients with emergency surgeries or re-do surgeries.
- Systemic infections or infections at the site of injection.
See the full eligibility criteria
- Patients aged 18-70 years.
- Patients scheduled for unilateral Thoracotomy.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Patients who are candidates for general anesthesia.
- No history of severe allergies to local anesthetics or other medications used during the procedure.
- ASA PS class ≥ IV patients.
- obese (BMI ≥ 35) patients.
- Patients with uncontrolled cardiovascular.
- patients with neurological deficits, cardiopulmonary, hepatorenal , or metabolic diseases; anticoagulants; any drug allergies.
- Patients with emergency surgeries or re-do surgeries.
- Systemic infections or infections at the site of injection.
- Psychiatric illnesses (schizophrenia, bipolar, uncontrolled anxiety or depression).
- Narcotic dependency.
The study team makes the final eligibility decision.
Where it's taking place
- El Fayoum Qesm, Faiyum Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include El Fayoum Qesm, Faiyum Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.